About SIGA Technologies Inc.
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.
2BB score and signals
SIGA Technologies Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 8 | Very Low |
| Momentum | 27 | Weakening |
| Financial strength | 37 | Weak |
| Quality | 60 | Strong |
| Risk | 38 | Low |
Company facts
| CEO | Diem Nguyen |
| Founded | Dec 28, 1995 |
| Employees | 49 |
| 52-week range | $2.83 – $9.45 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | — | — | — |
| 2026-08-06 | — | — | — | — |
| 2026-05-07 | -0.05 | — | $6.24M | — |
| 2026-03-10 | -0.08 | — | $3.79M | — |
Related companies